The period in summary

First quarter, January-March 2023

• Net sales increased with close to 40% compared to the same period 2022
• The Board of Directors resolved on a share issue, with subsequent approval by the EGM
• The Company raised approx. SEK 6,1 million* through a rights issue of shares
• The first instalment of the EDF grant was paid, amounting to approx. SEK 1,8 million

*before deduction of transaction related costs

Key Figures

*Adjusted for new share issue

Comments from CEO Elin Mignérus

Q1 2023 has been largely focusing on financing activities for Polymer Factory; raising capital during a volatile market period while continuing to deliver on our day-to-day operations. We have made progress in both technology development and customer relationships, which we are excited to build on during the rest of the year.

The start of 2023 has meant a lot of focus on financing activities for Polymer Factory, both considering the share issue that was conducted in February-March, as well as the announcement of the European Defense Fund (EDF) grant that the Company

was approved for in the end of 2022. As communicated in previous reports and updates, the Board of Directors have continuously evaluated options for long-term financing, which led to the resolution on a rights issue in January, which the Extra General Meeting subsequently approved. We are happy to have successfully secured funding in a financially challenging market, and I would like to take this opportunity to welcome all new shareholders to Polymer Factory, and of course also show our appreciation for everyone who has continued to be a part of our journey.

In January, Polymer Factory received the first instalment out of three under the EDF grant for the project Nano-SHIELD. We are excited to be part of this consortium of international partners where we will be working to develop tomorrow’s protective equipment against chemical, biological, radiological, and nuclear threats (CBNR). This grant is beneficial to the Company for several reasons, the main being that it can open the door to new application areas for our materials, as well as the financial addition the grant brings, as Polymer Factory will be receiving approximately SEK 5 million over the three years of the project. Furthermore, we look forward to the spill over effects that this project can bring, in terms of learning and development that can be translated to other materials and products.

Net sales increased compared to the same period for the third consecutive quarter, which we attribute to the interest among customer leads who realize the potential of our materials. As always, we continue to work on existing relationships while engaging new leads, and I am proud of the commitment the team is constantly showing. We are a small company with great ambitions – something everyone is constantly working towards.

As we have presented during the share issue earlier this year, increasing our visibility and allocating resources to sales and marketing activities is something we are focusing on in 2023. An important part of this is the participation in conferences and fairs, and I am happy to say that Polymer Factory will be present at a booth and during presentations at this year’s American Society for Mass Spectrometry (ASMS) Conference in Houston in June. From previous years at ASMS, as well as during other events we have participated in this and earlier years, we have noticed that this is a great arena for the Company to market itself, both for the calibrants segment but also for our Dendrimers and dendrons segment. There is a clear overlap between the technologies, which also means that we can consolidate marketing efforts for different business areas.

We look forward to now take on the rest of 2023 and continue to develop the company together with customers, partners, and collaborators - and happy to get to share this progress together with all our shareholders.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 10-05-2023 08:00 CET.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.